Fortress Biotech (FBIO) Interest Expenses (2010 - 2026)

Fortress Biotech's Interest Expenses history runs 16 years deep, the most recent figure standing at $3.0 million for Q4 2025.

• In Q4 2025, Interest Expenses fell 51.01% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $18.2 million (up 6.13% YoY), while the FY2025 annual figure was $294.1 million, down 22.19% from the prior year.
• Interest Expenses for Q4 2025 stood at $3.0 million, up from $2.7 million in the prior quarter.
• The five-year high for Interest Expenses was $6.4 million in Q2 2023, with the low at -$2.5 million in Q4 2021.
• The 5-year median for Interest Expenses is $2.9 million (2021), against an average of $3.1 million.
• The sharpest annual moves came in 2021 and 2023: Interest Expenses plunged 213.32% in 2021, then soared 294.64% in 2023.
• Fortress Biotech's Interest Expenses stood at -$2.5 million in 2021, then surged by 121.09% to $522000.0 in 2022, then jumped by 294.64% to $2.1 million in 2023, then jumped by 200.34% to $6.2 million in 2024, then tumbled by 51.01% to $3.0 million in 2025.
• Business Quant data shows FBIO's Interest Expenses at $3.0 million in Q4 2025, $2.7 million in Q3 2025, and $3.2 million in Q2 2025.